Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort-Reference-Cited by-同舟云学术

Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort

Published:2022-12 Issue: Volume:72 Page:154148
ISSN:0883-9441
Container-title:Journal of Critical Care
language:en
Short-container-title:Journal of Critical Care

Author:

Linné Erik,Elfström Alma,Åkesson Anna,Fisher Jane,Grubb Anders,Pettilä Ville,Vaara Suvi T.,Linder Adam,Bentzer Peter

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine

Reference54 articles.

1. The third international consensus definitions for Sepsis and septic shock (Sepsis-3);Singer;JAMA.,2016

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study;Rudd;Lancet,2020

3. Acute kidney injury in sepsis;Bellomo;Intensive Care Med,2017

4. Sepsis-induced acute kidney injury;Martensson;Crit Care Clin,2015

5. Chronic kidney disease: an inherent risk factor for acute kidney injury?;Singh;Clin J Am Soc Nephrol,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential Role of CYP2D6*10(c.100 C>T) Gene Polymorphism in Kidney Injury of Patients with Hypertension Complicated with Non-Elevated Cystatin C;Cardiovascular Toxicology;2024-06-12

2. Acute Kidney Injury Prediction Model Using Cystatin-C, Beta-2 Microglobulin, and Neutrophil Gelatinase-Associated Lipocalin Biomarker in Sepsis Patients;International Journal of Nephrology and Renovascular Disease;2024-03

3. Estimated glomerular filtration rate among intensive care unit survivors: From the removal of race coefficient to cystatin C-based equations;Journal of Critical Care;2024-02

4. Use of cardiac troponin I, lactic acid, procalcitonin, and serum complement C3 as prognostic indicators in patients with sepsis;Medicine;2023-12-29

5. The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example;Antibiotics;2023-09-13